cepharanthine has been researched along with thiazoles in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aikou, T; Akiyama, S; Furukawa, T; Ikeda, R; Kitazono, M; Nagayama, S; Okumura, H; Seto, K; Sumizawa, T | 1 |
Fukumoto, M; Hata, K; Nakajima, A; Taura, K; Uchinami, H; Yamamoto, Y; Yamaoka, Y; Yonezawa, K | 1 |
2 other study(ies) available for cepharanthine and thiazoles
Article | Year |
---|---|
Reversal of LRP-associated drug resistance in colon carcinoma SW-620 cells.
Topics: Alkaloids; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Butyrates; Carcinoma; Cell Nucleus; Colonic Neoplasms; Coloring Agents; Cyclic P-Oxides; Cytoplasm; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Humans; Microscopy, Fluorescence; Neoplasm Proteins; Nicotinic Acids; RNA, Catalytic; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles | 2001 |
Beneficial effect of cepharanthine on overcoming drug-resistance of hepatocellular carcinoma.
Topics: Adenosine Triphosphatases; Aged; Alkaloids; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzylisoquinolines; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Coloring Agents; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Female; Flow Cytometry; Humans; Immunohistochemistry; Inhibitory Concentration 50; Kinetics; Liver Neoplasms; Male; Middle Aged; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Time Factors | 2004 |